| |
| |
|
| Insider
Information: |
Saik Andrew |
| Relationship: |
Chief Financial Officer |
| City: |
Chesterbrook |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
159,017 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$47,458 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
159,017 |
|
|
| Total
Value |
$47,458 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -26.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDS Biotechnology Corp |
PDSB |
|
2020-02-14 |
42,549 |
2019-03-15 |
0 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
Chief Financial Officer |
2021-05-28 |
116,468 |
2020-03-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-05-28 |
4 |
A |
$3.36 |
$10,130 |
D/D |
3,017 |
116,468 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-03-31 |
4 |
D |
$6.84 |
$5,212 |
D/D |
(762) |
113,451 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
29,213 |
114,213 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-09-08 |
4 |
B |
$1.46 |
$58,480 |
D/D |
40,000 |
340,000 |
2.74 |
% |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
300,000 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
Chief Financial Officer |
• – – |
2020-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• • – |
2020-02-14 |
4 |
A |
$1.30 |
$49,920 |
D/D |
38,400 |
42,549 |
0 |
- |
|
| PDSB |
PDS Biotechnology Corp |
Chief Financial Officer |
• • – |
2019-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
82,999 |
82,999 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
